under this Drug Safety Enhancement Act which Mr. Dingell and some of us introduced yesterday, would that give the FDA new authorities to address issues like intentional economic adulteration like in the heparin situation?
DeGette questions the effectiveness of the Drug Safety Enhancement Act regarding FDA authorities.
Share
More from Diana DeGette
We cannot allow the risk of imperfection in these programs to paralyze them as bridges crumble, as manufacturing lines stall for want of microchips, as the climate becomes increasingly hostile for our children and our grandchildren.
I feel like my message is getting out to the voters: fighting against Donald Trump, fighting for Medicare For All, and against ICE, and that’s what they care about.
I fight back, because that is the only thing this administration responds to. Colorado was the first state in 35 years to be denied a major disaster declaration, and Trump is still sitting on federal childcare and food aid that Coloradans…
Do you--what progress would you say HHS has made in improving the ability to provide for the, quote, 'medical and mental health needs of children in ORR care' that you mentioned in your testimony?
Other voices in this conversation
